Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Topas Therapeutics

Request full access

Harnessing the liver’s natural immunology capabilities to address areas of major unmet medical need

Hamburg, GermanyFounded 2013Biotech & Life Sciences

About Topas Therapeutics

Topas Therapeutics is a biotechnology company focused on developing innovative therapies for autoimmune diseases by leveraging the liver's natural tolerance induction capabilities. The company primarily serves patients suffering from conditions such as pemphigus vulgaris, a rare autoimmune disease. Operating in the biopharmaceutical market, Topas Therapeutics employs a business model centered around research and development, clinical trials, and eventual commercialization of its proprietary treatments. Revenue is generated through a combination of funding rounds, partnerships with larger pharmaceutical companies, and future sales of approved therapies. The company recently raised USD 26 million in Series B financing to further its research and development efforts. Key clients include healthcare providers, research institutions, and patients.

Source: Dealroom company data

At a glance

Status
Operational
Employees
21
Open positions
None listed
Dealroom signal
67.0/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Autoimmune, Chronic Disease, Sustainable Development Goals, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Jul 2021 $20M $121M Gimv · BioMedVC · Epidarex Capital · Boehringer Ingelheim Venture Fund —
SERIES BOther financing Oct 2020 $24M $97M Boehringer Ingelheim Venture Fund · EMBL Ventures · Evotec · BioMedVC —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Topas Therapeutics website traffic

Latest recorded traffic for Topas Therapeutics is 1.6K monthly website visits, up 14.3% over the last three months. Topas Therapeutics's team grew 5% over the past year.

Latest monthly visits1.6K 3-month web change+14.3% 1-year team growth+5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Topas Therapeutics in the Hamburg ecosystem

Live from Dealroom

The Topas Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A7 investors entered at this stage

  • Epidarex Capital
  • EMBL Ventures
  • Gimv
  • Evotec
  • Boehringer Ingelheim Venture Fund
  • BioMedVC
  • Vesalius Biocapital Partners
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇩🇪 Germany75%
🇬🇧 United Kingdom6.3%
🇨🇭 Switzerland6.3%
🇧🇪 Belgium6.3%
🇦🇹 Austria6.3%
5 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Topas Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Topas Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.